Xanthine derivative and DPPIV inhibitor
US7074798B2 · kind B2 · utility
103Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2003 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Mar 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds exhibiting an excellent DPPIV inhibition effect.The compounds are represented by the formula:wherein, m is 0 or 1;
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.